News
EscharEx - MediWound
02/20/2025
MediWound announces initiation of the VALUE Global Phase III Pivotal Trial of EscharEx for debridement and wound closure in the treatment of VLUs. The study will enroll 216 patients and will be conducted across 40 sites in the US and Europe. An interim analysis is expected in H126.


